Skip to content
Search

Latest Stories

India bans export of Covid-19 treatment drug remdesivir

India bans export of Covid-19 treatment drug remdesivir

India on Sunday (11) banned the export of remdesivir as infections soared to a new daily high and hospitals grappled with increasing demand for the coronavirus treatment drug.

The vast nation has experienced a sharp rise in cases in recent weeks, adding 152,000 new cases on Sunday to take the toll to 13.3 million infections.


The health ministry said the surge in cases has led to a "sudden spike in demand" for the antiviral drug.

"There is a potential of further increase in this demand in the coming days," the ministry said in a statement, adding that the export ban would be in place "till the situation improves".

Remdesivir, made by US pharma giant Gilead, was one of the first drugs to show relative promise in shortening the recovery time for some Covid-19 patients.

But a World Health Organisation-backed study has said that the drug had "little or no effect" on Covid-19 mortality.

Gilead last year signed licensing agreements with generic pharmaceutical producers based in India, Pakistan and Egypt, allowing them to manufacture remdesivir for distribution in 127 mostly low and lower-middle income nations.

Seven firms in India -- the world's biggest producer of generic drugs -- are licensed to manufacture remdesivir.

They have a monthly production capacity of up to 3.88 million injection doses, the ministry added.

The ban came as India's wealthiest state Maharashtra, which has been the main driver of the infection spike, explored announcing a complete lockdown from as early as Monday.

India had shied away from harsh restrictions since a months-long nationwide lockdown -- one of the strictest in the world -- was gradually lifted last year, amid fears of shattering the already battered economy.

But local authorities have increasingly imposed restrictions, including Maharashtra's weekend lockdown and night curfew, as cases continue to rise.

The chief minister of Delhi, India's capital, said Sunday that his government was not in favour of a lockdown, but would consider the drastic measure if hospital beds start running out.

He added that 65 percent of new Covid-19 patients were less than 45 years old.

India, home to the world's biggest vaccine manufacturer, has meanwhile slowed its export of shots due to the spike as several states have warned in recent days that their stocks were running low.

Prime Minister Narendra Modi on Sunday launched a four-day "vaccine festival" to kick start a "second battle against corona" in a bid to speed up a sluggish vaccination rollout.

More For You

Turkey wildfires 2025

The Turkey wildfires have not been limited to Izmir

Getty Images

Turkey wildfires disrupt travel as Izmir airport closes

Key points

  • Tourists stranded after Foça wildfire halts flights at Izmir airport
  • At least 550 people evacuated from homes in the region
  • Over 600 personnel deployed to contain the blaze
  • Strong winds and heat raise risk of further fires

Wildfires force airport shutdown in Turkish holiday hotspot

Hundreds of UK tourists, including several from Glasgow, have been left stranded after major wildfires swept through a popular holiday destination in western Turkey, forcing the closure of Izmir Adnan Menderes Airport.

The blaze broke out in the resort town of Foça, near Izmir, and was rapidly intensified by strong winds, prompting large-scale evacuations and flight disruptions. All operations at the airport were suspended from 4 pm local time due to ongoing extinguishing efforts, with multiple flights reportedly diverted.

Keep ReadingShow less
Shefali Jariwala

Glutathione and anti ageing drugs under spotlight after Shefali Jariwala death

Instagram/shefalijariwala

Did anti-ageing pills, beauty supplements and glutathione trigger Shefali Jariwala’s death?

Quick highlights:

  • Shefali Jariwala died at 42 in Mumbai after reportedly collapsing post-fast; cause of death suspected to be cardiac arrest or blood pressure drop.
  • Police found anti-ageing pills, vitamin supplements, and glutathione injections at her residence.
  • Doctors stress the risks of unsupervised use of hormone-based and anti-ageing treatments.
  • Final post-mortem report expected in two days; no foul play suspected, case treated as accidental death.

The untimely death of actor-model Shefali Jariwala has sparked renewed concern over the unregulated use of anti-ageing treatments and self-medication. The 42-year-old, best known for her appearance in Kaanta Laga, was declared dead on arrival at a Mumbai hospital on Friday night. Initial investigations suggest she may have suffered a cardiac arrest following a steep drop in blood pressure, possibly linked to taking supplements on an empty stomach.

Keep ReadingShow less
Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less